MeSH Review:
Cytopathogenic Effect, Viral
- Human immunodeficiency virus type 1 Vpu modifies viral cytopathic effect through augmented virus release. Iwatani, Y., Song, S.K., Wang, L., Planas, J., Sakai, H., Ishimoto, A., Cloyd, M.W. J. Gen. Virol. (1997)
- Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Greenway, A.L., McPhee, D.A., Grgacic, E., Hewish, D., Lucantoni, A., Macreadie, I., Azad, A. Virology (1994)
- Herpes simplex virus type 1 replication and IL-1 beta gene expression in mouse peritoneal macrophages activated in vivo by an attenuated Salmonella typhimurium vaccine or Corynebacterium parvum. Wu, L., Morahan, P.S., Hendrzak, J.A., Eisenstein, T.K. Microb. Pathog. (1994)
- The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming. Antalis, T.M., La Linn, M., Donnan, K., Mateo, L., Gardner, J., Dickinson, J.L., Buttigieg, K., Suhrbier, A. J. Exp. Med. (1998)
- Effectiveness of acycloguanosine and trifluorothymidine as inhibitors of cytomegalovirus infection in vitro. Lang, D.J., Cheung, K.S. Am. J. Med. (1982)
- Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. Salvant, B.S., Fortunato, E.A., Spector, D.H. J. Virol. (1998)
- Uptake of [125I]iododeoxycytidine by cells infected with herpes simplex virus: a rapid screening test for resistance to acyclovir. Van Dyke, R.B., Connor, J.D. J. Infect. Dis. (1985)
- Enhanced production of morbillivirus gene-specific RNAs following induction of the cellular stress response in stable persistent infection. Oglesbee, M.J., Kenney, H., Kenney, T., Krakowka, S. Virology (1993)
- A polymorphism in the poliovirus receptor gene differs in motor neuron disease. Saunderson, R., Yu, B., Trent, R.J., Pamphlett, R. Neuroreport (2004)
- Inhibition of in vitro HIV infection by trinitrophenyl-protein conjugates. Matsiota-Bernard, P., Guetard, D., Rame, V., Montagnier, L., Avrameas, S. Res. Immunol. (1995)
- Inhibition of the multiplication of enveloped and non-enveloped viruses by glucosamine. Delgadillo, R.A., Vanden Berghe, D.A. J. Pharm. Pharmacol. (1988)
- In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus. Povey, R.C. Am. J. Vet. Res. (1978)
- Streptovirudins -- new antibiotics with antiviral activity. The antiviral spectrum and inhibition of Newcastle disease virus in cell cultures. Tonew, E., Tonew, M., Eckardt, K., Thrum, H., Gumpert, B. Acta Virol. (1975)
- Antiviral effects of recombinant human tumor necrosis factor. Ito, M., O'Malley, J.A. Lymphokine Res. (1987)
- Severe acute respiratory syndrome, a pathological immune response to the new coronavirus--implications for understanding of pathogenesis, therapy, design of vaccines, and epidemiology. Bermejo, J.F., Muñoz-Fernandez, M.A. Viral Immunol. (2004)
- MVM(p) NS-2 protein expression is required with NS-1 for maximal cytotoxicity in human transformed cells. Legrand, C., Rommelaere, J., Caillet-Fauquet, P. Virology (1993)